Endocrine approach in the treatment of obesity: Is there any space for the adiponectin action?

Rok, strany: 2020, 157 - 159

Adiponectin is a hormone secreted by adipose tissue, exerting many positive effects in the human body. Its action has been widely studied, placing it into the metabolic health beneficial products of the adipose tissue. Nevertheless, adiponectin has been shown to exert some extra beneficial non metabolic actions, as well. Adiponectin levels can be related to reduced incidence of cancer in obese patients. Moreover, adiponectin has been shown to be implicated in the positive fertility outcomes of women. Some new studies have also indicated that adiponectin has a potential effect in the control of appetite, which raises a question, whether the adiponectin could be accredited to be useful in the endocrine evaluation of obesity. Could these additional non-metabolic actions prove its helpfulness?

ISO 690:

Michalakis, K. 2020. Endocrine approach in the treatment of obesity: Is there any space for the adiponectin action?. In ENDOCRINE REGULATIONS, vol. 54, no.3, pp. 157-159. 1210-0668. DOI: https://doi.org/10.2478/enr-2020-0018

APA:

Michalakis, K. (2020). Endocrine approach in the treatment of obesity: Is there any space for the adiponectin action?. ENDOCRINE REGULATIONS, 54(3), 157-159. 1210-0668. DOI: https://doi.org/10.2478/enr-2020-0018

Vydavateľ: Sciendo